VB Spine LLC (“VB Spine”), the largest privately held spine company, today announced it has completed its acquisition of the exclusive rights to Augmedics’ CT-to-fluoroscopy (CT-Fluoro) technology for spine applications and will immediately begin integrating the technology into the xvision Spine System® platform.
“We are pleased to complete this transaction and continue building on the momentum of our technology portfolio,” said Marc Viscogliosi, co-CEO of VB Spine, speaking on behalf of his brothers, Anthony and John Viscogliosi. “The addition of CT-Fluoro technology to xvision reflects our commitment to equipping surgeons with advanced navigation solutions that support a wide range of spine procedures.”
CT-Fluoro technology uses a patient’s preoperative CT scan together with fluoroscopic images from a standard 2D C-arm to support augmented reality (AR) during spine procedures. With xvision, it adds a registration method that expands the imaging options available to surgeons.
“Incorporating CT-Fluoro technology into spine surgery workflows gives more surgeons in more settings the opportunity to adopt AR navigation as a standard for their practice, particularly in regional hospitals and ambulatory surgery centers where traditional intraoperative 3D imaging and navigation systems are cost-prohibitive,” said Dr. Frank Phillips of Midwest Orthopedics at Rush University Medical Center and the first surgeon who completed the world’s first AR-navigated minimally invasive spine surgery, a lumbar fusion with spinal implants on a patient with spinal instability. “In my own ASC practice, the ability to use AR off a preoperative CT has been game-changing. After two standard intraoperative fluoroscopic images and a minute or two of registration, I’m able to proceed directly with AR-guided surgery.”
VB Spine and Augmedics are working together to ensure a seamless transition of the technology.
Read Also: Revvity Launches SuperFlex Prenatal Screening System, Expanding Access to Preeclampsia Testing
